Hospital-Wide Standardization of Warnings about Driving Motor Vehicles While Taking Drugs: An Example from Nagoya City East Medical Center (Part 2)
10.11256/jjdi.17.164
- VernacularTitle:医薬品服用中における自動車運転等の注意喚起徹底に関する 院内統一（第二報)
- Author:
Yasuhisa Hattori
;
Yukiko Okamoto
;
Yasuo Nakamura
;
Kaoru Kamimoto
;
Hiroshi Suzumura
- Publication Type:Journal Article
- Keywords:
motor vehicle driving;
warning;
drug administration guidance;
hospital-wide standardization
- From:Japanese Journal of Drug Informatics
2015;17(3):164-168
- CountryJapan
- Language:English
-
Abstract:
Objective: When vehicular accidents occur as a result of impaired consciousness etc., because of adverse drug reactions, there is a risk that third parties may be harmed. Till date, at Nagoya City East Medical Center (hereinafter, our hospital), the warnings about driving motor vehicles while taking drugs has varied depending on the doctor or pharmacist who provides the guidance. Therefore, throughout our hospital, we aimed to standardize these warnings and to introduce measures to strictly enforce them.
Methods: Among all the drugs used at our hospital, we identified those with warnings on the package insert about driving motor vehicles and classified them in accordance with “The Drug Administration Guidance Criteria Regarding the Driving of Vehicles,” created by our hospital on the basis of descriptions on the package insert and the level of risk of taking drugs. We then standardized the warnings about driving motor vehicles while taking drugs, throughout our hospital.
Results: Of the 1,416 drugs used at our hospital, we identified 294 (21%) with warnings about driving motor vehicles on the package insert, and more than half of these (158 drugs) had warnings about the prohibition of driving motor vehicles on the package insert. As a result of classifying the drugs according to “The Drug Administration Guidance Criteria Regarding the Driving of Vehicles,” we identified 53 drugs with warnings about the prohibition of driving motor vehicles. By the classification of the level of risk of taking drugs while driving motor vehicles and the hospital-wide standardization of the warnings about driving motor vehicles while taking drugs, we are now able to provide drug administration guidance in the form of warnings that are customized to the level of risk of using each drug.
Conclusion: These measures have clarified the level of risk of taking each drug and warnings about driving motor vehicles while taking them. In the future, we intend to cooperate with local pharmacies to intervene in the prescription of drugs outside well as inside hospitals.
